The majority of clinically diagnosed cutaneous T‐cell lymphomas (CTCL) highly express the cell‐surface markers CC chemokine receptor 4 (CCR4) and/or CD25. The gene discussed is CCR4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.